LifeNet Health CEO Rony Thomas Recognized Among Top 50 Healthcare Technology CEOs of 2024
LifeNet Health CEO Rony Thomas Recognized Among Top 50 Healthcare Technology CEOs of 2024
January 9, 2025 (Virginia Beach, VA) - LifeNet Health is proud to announce that its President and CEO, Rony Thomas, has been named one of The Top 50 Healthcare Technology CEOs of 2024 by The Healthcare Technology Report. This prestigious recognition highlights Thomas’s exceptional leadership and unwavering commitment to advancing innovations in regenerative medicine and life sciences.
LifeNet Health Selected by the Henry M. Jackson Foundation to Recover Biospecimens to Study the Effects of CTE in Military Personnel
LifeNet Health Selected by the Henry M. Jackson Foundation to Recover Biospecimens to Study the Effects of CTE in Military Personnel
April 19, 2024 (Virginia Beach, Va.) - LifeNet Health, a global leader in regenerative medicine and the largest nonprofit organ procurement organization, biologics, and Life Sciences company in the United States, today announced an award from the Henry M. Jackson Foundation – the Bethesda, MD-based not-for-profit dedicated to advancing military medicine. The award is for LifeNet Health to recover biospecimens for the Foundation’s study on the effects of Chronic Traumatic Encephalopathy (CTE) in deceased military personnel.
LifeNet Health OPO sets new record in 2023
LifeNet Health OPO sets new record in 2023
Virginia Beach, Va. (Jan. 11, 2024) — LifeNet Health continues to save more lives than ever through organ donation, with 259 people donating 686 organs for transplant last year.
Both numbers represent all-time highs for the LifeNet Health Organ Procurement Organization, which saved 591 lives, working in partnership with hospitals and transplant centers across the region.
Corporate Darden Award Recognizes Civic Leadership
Corporate Darden Award Recognizes Civic Leadership
Virginia Beach, Va. (Nov. 16, 2023) — LifeNet Health has been selected as the 2023 Darden Award corporate honoree. This recognition highlights the company’s focus on giving healing every advantage through organ transplantation, allograft tissue implants, and cell-based research.
LifeNet Health LifeSciences Partners With CN Bio to Set a New Standard for Cell Quality and Performance
LifeNet Health LifeSciences Partners With CN Bio to Set a New Standard for Cell Quality and Performance
Virginia Beach, Va. (Sept. 6, 2023) — Microphysiological systems hold the promise of revolutionizing compound discovery and safety testing — but only if researchers have access to high-quality, reliable 3D cells. LifeNet Health LifeSciences has been at the forefront of addressing this challenge, and recently the organization took another key step by entering into an agreement to supply and distribute hepatic cells to CN Bio, a leading organ-on-a-chip company that manufactures single- and multi-organ MPS platforms.
LifeNet Health Again Named a Top Employer for Interns
LifeNet Health Again Named a Top Employer for Interns
Virginia Beach, Va. (July 27, 2023) — LifeNet Health has earned the Top Employer for Interns Award for the second year in a row.
This designation from the Virginia Talent + Opportunity Partnership (V-TOP) and 757 Regional Internship Collaborative, Region 5, is intended to help solidify Virginia as a top state for education, talent, and business.
LifeNet Health acquires best-in-class wound care portfolio
LifeNet Health acquires best-in-class wound care portfolio
The acquisition of Bioventus Inc.’s wound care division includes all its dedicated professionals
Virginia Beach, Va. (May 10, 2023) – LifeNet Health expands its portfolio of wound care solutions, adding revolutionary products such as TheraSkin®, with the acquisition of the Bioventus Inc. wound care division. This step strengthens LifeNet Health’s position as a global leader in regenerative medicine offering next-level wound care.
LifeNet Health LifeSciences launches TruVivo™, a pioneering all-human 2D+ hepatic system, to revolutionize compound discovery
LifeNet Health LifeSciences launches TruVivo™, a pioneering all-human 2D+ hepatic system, to revolutionize compound discovery
TruVivo, the largest co-culture advancement in more than a decade, is a novel hepatic in vitro 2D+ system comprised of all-human cells that mimics the microarchitecture and functionality of the human liver
TruVivo represents a new paradigm in hepatic testing by offering the simplicity and flexibility of a 2D model, along with the robust data of a 3D model
Pagination
- Page 1
- Next page